-

Novālent Welcomes Keivan Mehrtbar as Senior Director of Global Regulatory Affairs

GREENSBORO, N.C.--(BUSINESS WIRE)--Novālent Biotech, Inc (‘Novālent’), a US biotechnology engineering firm, welcomes Keivan Mehrtbar to its team as senior director of global regulatory affairs. Within this role he will guide regulatory strategy and implementation through the rapid growth the company recently experienced.

“We are fortunate to have someone with Keivan’s background on our team to help us navigate through the regulatory environment as we grow intelligently and quickly,” explains Kevin Parrish, CEO of Novālent. “His experience is going to lead the way in our ability to compete on the global stage as we consider the varying regulations of nations and municipalities in which we’re likely to participate.”

Mr. Mehrtbar brings 20 years of experience in the specialty chemicals industry having led regulatory affairs, quality control and product safety for several companies including Lonza Specialty Ingredients, one of the global leaders in microbial control solutions.

Novālent’s Technology has an extensive set of ‘industry first’ EPA registrations for long-term antimicrobial protection provided on food contact surfaces and is used by leading firms including PepsiCo, Sabra and Pilgrims.

“It’s such an interesting time to work within the regulatory environment, I’m glad to join the Novālent team as it expands and breaks new ground,” says Mr. Mehrtbar.

About Novālent

Novālent® is a leading U.S. biotechnology engineering firm which has pioneered the development of proprietary, long-lasting technology that protects against germs. Novālent® technology is based on a patented, non-toxic monomolecular layer that continuously inhibits the growth of bacteria for up to 90 days on surfaces. Used by leading US firms including PepsiCo, Pilgrims and HanesBrands, Novālent is private equity-backed and is headquartered in Greensboro, North Carolina, with five offices around the world. Visit www.novalent.com for more information.

Download a high-resolution photo of Mr. Mehrtbar.

Contacts

Christine Wetzler
christine@pietrylapr.com

Novālent Biotech, Inc


Release Summary
Novālent, a US biotechnology engineering firm, welcomes Keivan Mehrtbar to its team as senior director of global regulatory affairs.
Release Versions

Contacts

Christine Wetzler
christine@pietrylapr.com

More News From Novālent Biotech, Inc

Novālent is Now Available at Walmart Inc.

GREENSBORO, N.C.--(BUSINESS WIRE)--Novālent Biotech, Inc (‘Novālent’), a U.S. biotechnology engineering firm, is pleased to announce that after a nine-month review Novālent long lasting surface protection technology is available at Walmart stores in the United States. “Walmart is an important distribution partner given its unparallel scale and reach,” said Kevin Parrish, Novālent CEO. “By having our technology available readily throughout the US now means clients of all sizes can benefit from N...

Novālent Partners with Birko Corporation

GREENSBORO, N.C.--(BUSINESS WIRE)--Novālent Biotech, Inc (‘Novālent’), a U.S. biotechnology engineering firm, is partnering with Birko, a leader in providing integrated sanitation solutions in the brewing and distilling, produce, meat, poultry and protein industries. This partnership pairs two trusted brands to offer best-in-class residual antimicrobial solutions to food and beverage companies in North America. Novālent coating technology is for use as a residual antimicrobial under EPA and FDA...

Novālent is HACCP Certified

GREENSBORO, N.C.--(BUSINESS WIRE)--Novālent Biotech, Inc (‘Novālent’), a U.S. biotechnology engineering firm, is pleased to share its facilities are Hazard Analysis Critical Control Point (HACCP) certified. “Earning the GMP/HACCP certification in our manufacturing plant is a competitive advantage. This is a big deal when it comes to adding another layer of food safety for our food and beverage customers. In today’s world where there is a heightened awareness for food protection, this certificat...
Back to Newsroom